Background
==========

The folate cycle, in conjunction with one-carbon metabolism, facilitates nucleic acid synthesis and is responsible for the transfer of 1-carbon methyl groups to DNA and proteins. Methyl groups added onto cytosine residues in promoter region CpGs in genomic DNA are central to the regulation of gene expression \[[@B1],[@B2]\]. The role of folic acid (FA) in preventing neurodevelopmental disorders and birth defects has long been recognized, and as such, its use during pregnancy is strongly emphasized \[[@B3]-[@B5]\]. Dietary FA supplementation is credited with a greater than 70% reduction in the incidence of neural tube defects (NTDs) in the US \[[@B6]\]. There has been speculation that FA supplementation may be associated with certain aberrant conditions in children \[[@B7]-[@B9]\], and a clear understanding of this purported association is essential in view of the presence of significant amounts of synthetic FA in our diets. Earlier, we reported that exposure of lymphoblastoid cells to FA supplementation causes widespread changes in gene expression \[[@B10]\]. We suggested that the occurrence of such epigenetic changes during gestational development may impact the methylation status of DNA in the offspring's brain and cause altered gene expression. Because gestational development involves a highly orchestrated regulation of gene expression, such gene dysregulation may affect the development of the brain and may culminate in neuropsychiatric conditions. This could be a contributing factor to the increasing prevalence in recent years.

To test the hypothesis that excess FA supplementation could alter the methylation in the brains of offspring, 1 week prior to mating, a group of C57BL/6 J female mice were fed a custom AIN-93G amino acid-based diet (Research Diet, Inc., New Brunswick, NJ, USA), with FA at 0.4 mg/kg (low maternal folic acid, or LMFA) or 4 mg/kg (high maternal folic acid, or HMFA). FA at the 4 mg/kg level is above the range currently included in mice chow, whereas the 0.4 mg/kg level of FA has been found to be necessary for a normal healthy litter size \[[@B11]\]. FA at the 4 mg/kg level in mice roughly corresponds to the 4 mg/day dose in humans, which is the level of FA supplementation (4 mg/day) prescribed to women with a history of NTD pregnancy. We used an amino acid-based diet to precisely control the amount of FA in the diet. To understand the dynamics of DNA methylation, genomic DNA from the cerebral hemispheres of the offspring was isolated at postnatal day 1 segregated by gender, and high-resolution, single-base DNA methylation profiling was performed by using next-generation Illumina (Illumina Inc., San Diego, CA, USA) sequencing (details in the Methods section).

Results
=======

Global DNA methylation patterns of the offspring's cerebral hemispheres from high maternal folic acid
-----------------------------------------------------------------------------------------------------

The final DNA methylation map presented in this study represents the summary of three biological replicates \[[@B12],[@B13]\], with each mouse collected from an independent litter. On average, the sequence depths of unique CpG sites in our study were 4,647,138 (11 times) for male and 4,410,480 (14 times) for female DNA samples (Additional file [1](#S1){ref-type="supplementary-material"}: Table S1), and about 90% of the CpG islands were covered. To investigate the differentially methylated regions (DMRs), sequence alignment and Fisher's exact test or *t* test were performed for each CpG site that had at least five reads covered. Results of global methylation comparison revealed that approximately 16% of the CpG sites were differentially methylated in both male and female pups from HMFA (n = 43,010 for male, n = 57,602 for female). The majority of the CpG island-associated DMRs were either intergenic or in introns, whereas 18% to 19% were in exons, and approximately 7% were in promoter regions (Figure [1](#F1){ref-type="fig"}a, b). Several genes involved in neural functioning, brain development, and synaptic plasticity were differentially methylated (*P* \<0.05) in the CpG sites of the offspring from HMFA (Tables [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}, [3](#T3){ref-type="table"} and [4](#T4){ref-type="table"}, Additional file [2](#S2){ref-type="supplementary-material"}: Table S2, Additional file [3](#S3){ref-type="supplementary-material"}: Table S3, Additional file [4](#S4){ref-type="supplementary-material"}: Table S5, and Additional file [5](#S5){ref-type="supplementary-material"}: Table S6). The results of high-resolution global DNA methylation profiling indicated that maternal FA induces significant changes in the overall methylation patterns in the brains of the offspring. The correlations of the distribution of methylation ratios in male and female pups for the corresponding sites in LMFA and HMFA are shown in Additional file [6](#S6){ref-type="supplementary-material"}: Figures S1-S6, and the distributions of the overlapped sites between LMFA and HMFA male with that of LMFA and HMFA female differential methylation sites (*P* \<0.05) are shown as a hexbin plot in Additional file [7](#S7){ref-type="supplementary-material"}: Figures S7-S9.

![**Distribution of differentially methylated sites in CpG island sequences. (a)** Male low maternal folic acid (LMFA) versus high maternal folic acid (HMFA). **(b)** Female LMFA versus HMFA.](1756-8935-7-3-1){#F1}

###### 

List of hypermethylated CpG sites in the promoter of genes from high maternal folic acid diet

  **Chromosome**   **Start**   **End**     **Gene**          **Total CpG LMFA**   **Total CpG HMFA**   **Methylation difference**   ***P value***
  ---------------- ----------- ----------- ----------------- -------------------- -------------------- ---------------------------- ---------------
  **Male-CpG**                                                                                                                       
  Chr1             174430052   174430053   *Tagln2*          12                   5                    -0.80                        0.00
  Chr2             124976701   124976702   *Slc12a1*         9                    10                   -0.79                        0.00
  Chr2             163576501   163576502   *Ada*             7                    5                    -0.80                        0.01
  Chr5             110658438   110658439   *Ankle2*          10                   6                    -0.80                        0.01
  Chr7^a^          25654980    25654981    *Dmrtc2*          5                    5                    -1.00                        0.01
  Chr12^a^         112951515   112951516   *Bag5*            20                   5                    -0.80                        0.00
  Chr13            21533599    21533600    *Pgbd1*           11                   5                    -0.91                        0.00
  Chr14            12384528    12384529    *Ptprg*           15                   6                    -0.87                        0.00
  Chr16            4078495     4078496     *Trap1*           17                   20                   -0.85                        0.00
  Chr18^a^         25327450    25327451    *AW554918*        11                   10                   -0.80                        0.00
  Chr18            55150289    55150290    *Zfp608*          8                    5                    -0.80                        0.01
  ChrX             70963189    70963190    *Bcap31*          15                   7                    -0.80                        0.00
  **Female-CpG**                                                                                                                     
  Chr1             158239364   158239365   *Nphs2*           5                    5                    -0.80                        0.05
  Chr2             30141110    30141111    *Nup188*          10                   9                    -0.78                        0.00
  Chr2             93663150    93663151    *Ext2*            7                    9                    -0.78                        0.00
  Chr4             115456244   115456245   *Atpaf1*          10                   5                    -0.80                        0.01
  Chr7             4765788     4765789     *Ube2s*           12                   14                   -0.79                        0.00
  Chr7             116076508   116076509   *Eif3f*           8                    10                   -0.80                        0.00
  Chr9             43921237    43921238    *Rnf26*           10                   6                    -0.80                        0.01
  Chr9             43921243    43921244    *Rnf26*           10                   6                    -0.80                        0.01
  Chr9             70352700    70352701    *Rnf111*          7                    6                    -1.00                        0.00
  Chr11^a^         106640875   106640876   *Polg2*           8                    8                    -0.75                        0.01
  Chr12^a^         111517321   111517322   *Dio3*            8                    8                    -0.75                        0.01
  Chr13            3147545     3147546     *Speer6-ps1*      6                    5                    -0.80                        0.02
  Chr13            38751553    38751554    *Eef1e1*          10                   6                    -0.80                        0.01
  Chr16            18624289    18624290    *Gp1bb*           8                    5                    -0.75                        0.02
  Chr17            24806277    24806278    *Zfp598*          7                    6                    -0.86                        0.00
  Chr18^a^         51277441    51277442    *Prr16*           7                    5                    -0.80                        0.01
  Chr18            60932782    60932783    *Rps14*           5                    9                    -0.78                        0.02
  ChrX             7721523     7721524     *2900002K06Rik*   6                    13                   -0.76                        0.00
  ChrX^a^          155852426   155852427   *Mtap7d2*         14                   17                   -0.82                        0.00

^a^Methylation exclusively in the CpG island of promoter region. HMFA, high maternal folic acid; LMFA, low maternal folic acid.

###### 

List of hypomethylated CpG sites in the promoter of genes from high maternal folic acid diet

  **Chromosome**   **Start**   **End**     **Gene**          **Total CpG LMFA**   **Total CpG HMFA**   **Methylation difference**   ***P value***
  ---------------- ----------- ----------- ----------------- -------------------- -------------------- ---------------------------- ---------------
  **Male-CpG**                                                                                                                       
  Chr2             104335383   104335384   *Hipk3*           6                    10                   -0.80                        0.01
  Chr2             118590048   118590049   *A430105I19Rik*   6                    7                    -0.83                        0.00
  Chr2             164156736   164156737   *Svs5*            5                    6                    -0.83                        0.02
  Chr2             171789984   171789985   *1700028P15Rik*   17                   5                    -0.80                        0.00
  Chr4             135283630   135283631   *Il22ra1*         5                    5                    -0.80                        0.05
  Chr5             122070856   122070857   *Acad12*          6                    11                   -0.73                        0.01
  Chr7             3219409     3219410     *Mir291b*         8                    11                   -0.75                        0.00
  Chr7             7253725     7253726     *Clcn4-2*         6                    9                    -0.72                        0.01
  Chr7^a^          15208940    15208941    *Gm18756*         10                   12                   -0.83                        0.00
  Chr7             91836603    91836604    *2610206C17Rik*   6                    5                    -0.83                        0.02
  Chr8             34495178    34495179    *Purg*            5                    5                    -0.80                        0.05
  Chr8             73034757    73034758    *Uba52*           6                    6                    -0.83                        0.02
  Chr8             77516944    77516945    *Hmgxb4*          6                    15                   -0.77                        0.00
  Chr9             66892554    66892555    *Tpm1*            15                   6                    -0.73                        0.00
  Chr10            53239171    53239172    *Gm20597*         8                    7                    -0.75                        0.01
  Chr12            3235150     3235151     *1700012B15Rik*   16                   18                   -0.88                        0.00
  Chr13            53382125    53382126    *Ror2*            6                    5                    -0.80                        0.02
  Chr13            53382128    53382129    *Ror2*            6                    5                    -1.00                        0.00
  Chr13            97839933    97839934    *Fam169a*         5                    8                    -0.75                        0.02
  Chr13            100671338   100671339   *Cartpt*          5                    5                    -0.80                        0.05
  Chr14            67628989    67628990    *Bnip3l*          7                    8                    -0.75                        0.01
  Chr19            5690281     5690282     *Pcnxl3*          20                   13                   -0.80                        0.00
  **Female-CpG**                                                                                                                     
  Chr2             127618583   127618584   *1500011K16Rik*   11                   20                   -0.85                        0.00
  Chr5^a^          100468191   100468192   *Enoph1*          11                   5                    -0.71                        0.01
  Chr6^a^          52196197    52196198    *Hoxa11*          5                    5                    -0.80                        0.05
  Chr6             100476908   100476909   *1700049E22Rik*   10                   5                    -0.80                        0.00
  Chr7             26326796    26326797    *Ceacam2*         6                    15                   -0.77                        0.00
  Chr7             29528469    29528470    *Mrps12*          16                   5                    -0.80                        0.00
  Chr7             86988105    86988106    *Anpep*           12                   5                    -0.83                        0.00
  Chr8             87469964    87469965    *Rtbdn*           7                    6                    -0.86                        0.00
  Chr8             116657191   116657192   *Nudt7*           14                   5                    -0.71                        0.01
  Chr9             109833746   109833747   *Mtap4*           8                    14                   -0.71                        0.00
  Chr10            76992742    76992743    *Itgb2*           8                    7                    -0.71                        0.01
  Chr10            80846466    80846467    *Dohh*            8                    13                   -0.69                        0.00
  Chr11            88727116    88727117    *Akap1*           6                    5                    -0.80                        0.02
  Chr11            115184397   115184398   *Ush1g*           12                   5                    -0.75                        0.01
  Chr11            118204319   118204320   *BC100451*        20                   7                    -0.81                        0.00
  Chr11            119909421   119909422   *Aatk*            7                    5                    -0.71                        0.03
  Chr11            120051942   120051943   *2810410L24Rik*   10                   5                    -0.70                        0.02
  Chr12            52447904    52447905    *G2e3*            8                    5                    -0.75                        0.02
  Chr14^a^         63380523    63380524    *Ints6*           5                    6                    -0.80                        0.02
  Chr15            81561248    81561249    *Rangap1*         13                   5                    -0.72                        0.01
  Chr17            52020946    52020947    *Gm20098*         9                    7                    -0.71                        0.00
  Chr18            38762241    38762242    *Spry4*           6                    5                    -0.83                        0.02
  Chr18            60933042    60933043    *Rps14*           9                    8                    -0.76                        0.00
  Chr19            7070128     7070129     *Trpt1*           8                    6                    -0.71                        0.03

^a^Methylation exclusively in the CpG island of promoter region. HMFA, high maternal folic acid; LMFA, low maternal folic acid.

###### 

List of top 20 hypermethylated CpG sites in the gene body of genes from high maternal folic acid diet

  **Chromosome**   **Start**   **End**     **Gene**     **Total CpG LMFA**   **Total CpG HMFA**   **Methylation difference**   ***P value***
  ---------------- ----------- ----------- ------------ -------------------- -------------------- ---------------------------- ---------------
  **Male**                                                                                                                      
  Chr3             138455425   138455426   *Tspan5*     15                   20                   0.90                         0.00
  Chr4             119140980   119140981   *Rimkla*     21                   15                   0.79                         0.00
  Chr4             119140989   119140990   *Rimkla*     37                   16                   0.77                         0.00
  Chr4             119141016   119141017   *Rimkla*     21                   15                   0.79                         0.00
  Chr4             119610724   119610725   *Hivep3*     11                   9                    0.89                         0.00
  Chr8             87012542    87012543    *Cacna1a*    8                    12                   0.88                         0.00
  Chr8             94181294    94181295    *Fto*        28                   22                   0.79                         0.00
  Chr9             15678801    15678802    *Mtnr1b*     7                    10                   1.00                         0.00
  Chr9             106735686   106735687   *Vprbp*      12                   12                   1.00                         0.00
  Chr9             106735687   106735688   *Vprbp*      20                   10                   0.90                         0.00
  Chr9             110562402   110562403   *Ccdc12*     14                   22                   0.86                         0.00
  Chr10            115535492   115535493   *Ptprr*      14                   9                    0.86                         0.00
  Chr13            84421455    84421456    *Tmem161b*   8                    12                   0.88                         0.00
  Chr13            93030034    93030035    *Msh3*       363                  63                   0.83                         0.00
  Chr14            75232739    75232740    *Lrch1*      18                   10                   0.89                         0.00
  Chr15            89378341    89378342    *Shank3*     17                   9                    0.83                         0.00
  Chr18            37951652    37951653    *Pcdha4-g*   14                   10                   1.00                         0.00
  Chr18            60852504    60852505    *Ndst1*      12                   6                    1.00                         0.00
  Chr18            65119073    65119074    *Nedd4l*     18                   17                   0.89                         0.00
  Chr19            31290367    31290368    *Prkg1*      17                   16                   0.76                         0.00
  **Female**                                                                                                                    
  Chr2             25434932    25434933    *Gm996*      9                    13                   0.85                         0.00
  Chr3             30935498    30935499    *Prkci*      10                   8                    1.00                         0.00
  Chr3             103739555   103739556   *Rsbn1*      9                    15                   0.89                         0.00
  Chr4             126102080   126102081   *Eif2c3*     19                   17                   0.74                         0.00
  Chr4             140978449   140978450   *Hspb7*      6                    19                   0.83                         0.00
  Chr4             150546918   150546919   *Camta1*     22                   6                    0.83                         0.00
  Chr5             65200088    65200089    *Klf3*       47                   36                   0.72                         0.00
  Chr5             103970283   103970284   *Ptpn13*     23                   12                   0.74                         0.00
  Chr5             131698838   131698839   *Wbscr17*    21                   16                   0.73                         0.00
  Chr7             53799845    53799846    *Sergef*     14                   21                   0.71                         0.00
  Chr8             35200739    35200740    *Leprotl1*   25                   10                   0.76                         0.00
  Chr9             8001572     8001573     *Yap1*       11                   15                   0.73                         0.00
  Chr9             42341123    42341124    *Grik4*      39                   30                   0.73                         0.00
  Chr10            88898375    88898376    *Gas2l3*     14                   11                   0.82                         0.00
  Chr11            3211676     3211677     *Gm11944*    10                   35                   0.74                         0.00
  Chr11            115670841   115670842   *Caskin2*    8                    14                   0.86                         0.00
  Chr14            58310412    58310413    *Lats2*      6                    24                   1.00                         0.00
  Chr16            34322324    34322325    *Kalrn*      12                   14                   0.71                         0.00
  Chr17            86912790    86912791    *Prkce*      8                    18                   0.89                         0.00
  Chr19            25161873    25161874    *Dock8*      16                   12                   0.75                         0.00

HMFA, high maternal folic acid; LMFA, low maternal folic acid.

###### 

List of top 20 hypomethylated CpG sites in the genebody of genes from high maternal folic acid diet

  **Chromosome**   **Start**   **End**     **Gene**          **Total CpG LMFA**   **Total CpG HMFA**   **Methylation difference**   ***P value***
  ---------------- ----------- ----------- ----------------- -------------------- -------------------- ---------------------------- ---------------
  **Male**                                                                                                                           
  Chr1             182625573   182625574   *Mixl1*           28                   10                   -0.76                        0.00
  Chr2             25376181    25376182    *Traf2*           24                   14                   -0.77                        0.00
  Chr3             37380649    37380650    *Spata5*          14                   18                   -0.78                        0.00
  Chr5             145038432   145038433   *Baiap2l1*        58                   20                   -0.87                        0.00
  Chr5             145038431   145038432   *Baiap2l1*        28                   20                   -0.73                        0.00
  Chr6             63336567    63336568    *Grid2*           12                   11                   -0.83                        0.00
  Chr8             119917212   119917213   *Cmip*            12                   10                   -0.80                        0.00
  Chr9             49203682    49203683    *Drd2*            14                   7                    -0.93                        0.00
  Chr10            86298137    86298138    *Nt5dc3*          20                   6                    -0.83                        0.00
  Chr11            89264853    89264854    *4932411E22Rik*   12                   8                    -1.00                        0.00
  Chr11            88387073    88387074    *Msi2*            11                   10                   -0.90                        0.00
  Chr12            73229241    73229242    *Ccdc175*         19                   6                    -0.83                        0.00
  Chr13            117804995   117804996   *Parp8*           12                   6                    -1.00                        0.00
  Chr16            49910445    49910446    *Cd47*            8                    10                   -1.00                        0.00
  Chr16            96296259    96296260    *Brwd1*           24                   8                    -0.83                        0.00
  Chr17            80761785    80761786    *Arhgef33*        20                   13                   -0.77                        0.00
  Chr17            64485735    64485736    *Fert2*           9                    14                   -0.82                        0.00
  Chr18            36751828    36751829    *Ankhd1*          20                   10                   -0.90                        0.00
  Chr19            5690281     5690282     *Map3k11*         20                   13                   -0.80                        0.00
  ChrX             98171409    98171410    *Tex11*           10                   6                    -1.00                        0.00
  **Female**                                                                                                                         
  Chr1^a^          106890569   106890570   *Cdh20*           15                   14                   -0.73                        0.00
  Chr3             53010469    53010470    *Lhfp*            12                   10                   -0.92                        0.00
  Chr4             137849617   137849618   *Kif17*           9                    14                   -0.86                        0.00
  Chr4             142704605   142704606   *Prdm2*           15                   11                   -0.73                        0.00
  Chr4             21913536    21913537    *6230409E13Rik*   23                   10                   -0.71                        0.00
  Chr4             46546442    46546443    *Trim14*          16                   11                   -0.75                        0.00
  Chr4             117003265   117003266   *Rnf220*          16                   6                    -0.83                        0.00
  Chr5             148775977   148775978   *Mtus2*           20                   14                   -0.76                        0.00
  Chr5             37274842    37274843    *Ppp2r2c*         14                   17                   -0.75                        0.00
  Chr8             121359642   121359643   *Cdh13*           17                   10                   -0.74                        0.00
  Chr9             21909321    21909322    *Cnn1*            10                   6                    -1.00                        0.00
  Chr9             44605440    44605441    *Tmem25*          16                   10                   -0.75                        0.00
  Chr11            96309521    96309522    *Gm11529*         25                   10                   -0.88                        0.00
  Chr11            118204319   118204320   *Timp2*           20                   7                    -0.81                        0.00
  Chr11            98634354    98634355    *Nr1d1*           7                    15                   -0.87                        0.00
  Chr15            99627500    99627501    *Lima1*           25                   22                   -0.74                        0.00
  Chr15            59208541    59208542    *Nsmce2*          9                    6                    -1.00                        0.00
  Chr16            49910445    49910446    *Cd47*            10                   12                   -0.83                        0.00
  Chr17            26016873    26016874    *Wfikkn1*         36                   20                   -0.73                        0.00
  Chr17            28437426    28437427    *Ppard*           8                    22                   -0.83                        0.00

^a^Methylation exclusively in the CpG island. HMFA, high maternal folic acid; LMFA, low maternal folic acid.

Maternal folic acid alters DNA methylation status in the promoters at CpG Islands
---------------------------------------------------------------------------------

In this study, we found that HMFA throughout gestation resulted in hypermethylation (*P* \<0.01) at CpG sites of the promoter region of several genes, including *Ada*, *Bag5*, and *Trap1* in male offspring (Table [1](#T1){ref-type="table"}), leading to downregulation of the expression of *Ada* and *Bag5* and no such alterations in expression level of *Trap1* (Figure [2](#F2){ref-type="fig"}a). In female pups, HMFA also resulted in hypermethylation at CpG sites in the promoter region of the genes *Dio3*, *Polg2*, *Rnf111*, and *Ube2s*, including several other genes (Table [1](#T1){ref-type="table"}). Quantitative real time reverse transcription-polymerase chain reaction (qRT-PCR) analysis revealed that the expression of *Dio3* was significantly downregulated and that, in contrast, the expression of *Polg2*, *Rnf111*, and *Ube2s* remained unchanged in female pups from HMFA compared with that of LMFA (Figure [2](#F2){ref-type="fig"}b). To further reveal the impact of maternal FA, we assessed whether HMFA resulting in hypomethylation in the promoter regions of CpG islands altered the expression levels of those genes as well. We tested the expression of several genes in male (*Pcnxl3*, *Hmgb21l*, and *Ror2*) and female (*Mrps12*, *Ceacam2*, and *Mtap4*) pups (Table [1](#T1){ref-type="table"}, Figure [2](#F2){ref-type="fig"}c, d). In male pups from HMFA, the expressions of *Ror2* and *Mrps12* were significantly downregulated, and in female pups, the expression of *Mtap4* was significantly upregulated in comparison with LMFA. Interestingly, although the methylation level of *Mrps12* did not show any significant change in male pups from HMFA, the expression was significantly downregulated. In contrast, the expression of *Mrps12* in female pups from HMFA showed no difference in expression level, although significant methylation changes were observed. However, the expression analysis of several other genes---*Pcnxl3*, *Hmgb21l*, *Mtap4*, and *Ceacam2*---has shown no significant changes in both the genders from HMFA. The results of our findings suggest that maternal FA modulates the methylation pattern of the offspring genome, and considering the role of maternal nutrition in early neural development, such changes in methylation patterns in promoter CpG sites due to HMFA may have long-term influences on neuronal organization and ultimately on behavioral phenotypes.

![**Relative expression of the genes that exhibited hypermethylation (a, b) and hypomethylation (c, d).** The results were normalized to *Hprt* transcript expression and were expressed as relative values in comparison with corresponding transcripts from low maternal folic acid (LMFA). Results represent mean ± standard deviation (SD); asterisks denote statistically significant change (*\*P \<*0.05, \*\**P \<*0.01, *\*\*\*P \<*0.001).](1756-8935-7-3-2){#F2}

Maternal folic acid alters DNA methylation status in the promoters at non-CpG sites
-----------------------------------------------------------------------------------

To extend our findings, we then analyzed whether gestational FA modulates the methylation pattern of non-CpG sites. In this study, we obtained 89% coverage in non-CpG sites (both CHH and CHG context, where H = A, C, or T). The overall distribution of methylation level in the non-CpG sites is shown in Additional file [8](#S8){ref-type="supplementary-material"}: Figures S10 and 11. We identified approximately 1,000 differentially methylated (both hyper- and hypo-methylation) sites (*P* \<0.05) in both CHH and CHG contexts in the offspring genome from the HMFA group (Additional file [2](#S2){ref-type="supplementary-material"}: Table S2, Additional file [3](#S3){ref-type="supplementary-material"}: Table S3, Additional file [9](#S9){ref-type="supplementary-material"}: Table S4, Additional file [4](#S4){ref-type="supplementary-material"}: Table S5, and Additional file [5](#S5){ref-type="supplementary-material"}: Table S6). For example, zinc finger proteins *Zfp608* and ephrin receptor *Epha6* in male offspring and *Zfp719*, *Zfp804b*, *Zfp128* and calcium channel *Cacna1g* in female offspring are a few of the many genes that were hypermethylated (*P* \<0.05) in the non-CpG promoter sites (Additional file [9](#S9){ref-type="supplementary-material"}: Table S4). Furthermore, we tested expression levels of several genes (*Ghr*, *Slc5a1*, and *4732418C07Rik*) in male pups and (*Tshz3* and *Trim7*) in female pups with Quantitative real time reverse transcription-polymerase chain reaction (qRT-PCR). The results showed that the expression of EF-hand calcium-binding domain 14 (*4732418c07Rik*) remain unchanged; in contrast, the expression of sodium-dependent glucose transporter (*Slc5a1*), which exhibited hypermethylation in CHG sites, and growth hormone receptor (*Ghr*) \[[@B14]\], which exhibited hypermethylation at both CHG and CHH sites in the promoter region, were downregulated in male offspring from HMFA (Figure [2](#F2){ref-type="fig"}a, Additional file [9](#S9){ref-type="supplementary-material"}: Table S4). A representative figure depicting the methylation status of a non-CpG (CHG) hypermethylation at *Slc5a1* promoter of male offspring from the data uploaded in the UCSC Genome Browser is shown in Additional file [10](#S10){ref-type="supplementary-material"}: Figure S12.

Maternal folic acid alters DNA methylation pattern in the gene body
-------------------------------------------------------------------

An interesting aspect of our data is the pattern of methylation in both CpG and non-CpG sites in gene bodies. The majority of the non-CpG associated DMRs were either intergenic or in introns, whereas 10% to 11% were in exons, and approximately 16% to 21% were in promoter regions in both male and female pups from HMFA (Figure [3](#F3){ref-type="fig"}a, b). The overall distribution of methylation level in exons is shown in Additional file [11](#S11){ref-type="supplementary-material"}: Figure S13 and S14. Several candidate autism susceptibility genes \[[@B15]\] were hypermethylated (*P* \<0.05) in the HMFA, including *Shank3*, *Cacana1g*, *Gtf2i*, *Rapgef4*, and *Nbea* in male offspring and *Ext1*, *Ube3a*, *Erbb4*, *Grip1*, *Grm8*, *Reeln*, *Shank3*, and *Rbfox1* in female offspring (Additional file [2](#S2){ref-type="supplementary-material"}: Table S2 and Additional file [3](#S3){ref-type="supplementary-material"}: Table S3). In contrast, several candidate autism susceptibility genes were also hypomethylated; for example, *Disc1*, which is known to play a pivotal role in cortical development, and *Scn8a*, which modulates membrane depolarization, were hypomethylated in the gene body in both male and female offspring (*P* \<0.05) in the HMFA group (Additional file [4](#S4){ref-type="supplementary-material"}: Table S5 and Additional file [5](#S5){ref-type="supplementary-material"}: Table S6). It is interesting to note that autism susceptibility candidate 2 (*Auts2*) gene exhibited both hyper- and hypo-methylation in the gene bodies of male and female pups from HMFA. Further analysis of methylation profile also revealed hypermethylation in imprinted genes in male (*Slc22a3* and *Ano1*) and in female (*Gab1*, *Calcr*, *Dio3*, and *Slc38a4*) offspring (*P* \<0.05) (Additional file [2](#S2){ref-type="supplementary-material"}: Table S2 and Additional file [3](#S3){ref-type="supplementary-material"}: Table S3). On the other hand, imprinted genes *Peg12* and *Slc22a18* in female offspring and cadherin-associated protein *Ctnna3* in both male and female offspring from the HMFA group were hypomethylated (Additional file [4](#S4){ref-type="supplementary-material"}: Table S5 and Additional file [5](#S5){ref-type="supplementary-material"}: Table S6). To verify changes in the expression levels, we tested the mRNA expression of several genes by qRT-PCR. Genes in male pups (*Auts2*, *Mthfd1l*, *Mtnr1b*, *Nfix*, *Otoa*, *Runx1*, *Shank3*, *Slc22a3*, and *Wif1*) and in female pups (*Auts2*, *Gab1*, *Lats2*, *Runx1*, *Wif1*, *Mthfd1*, *Shank3*, and *Slc25a13*) were analyzed. The results revealed that the expressions of *Auts2*, *Nfix*, *Otoa*, *Runx1*, *Shank3*, and *Slc22a3* were significantly downregulated; in contrast, the expression of *Mthfd1l*, *Mtnr1b*, and *Wif1* did not exhibit significant changes as a result of HMFA in comparison with LMFA in male pups (Figure [2](#F2){ref-type="fig"}a). In female pups from the HMFA group, the expression of *Auts2*, *Gab1*, *Lats2*, *Runx1*, *Wif1*, and *Mthfd1* did not exhibit significant changes; in contrast, the expressions of *Shank3* and *Slc25a13* were significantly downregulated (Figure [2](#F2){ref-type="fig"}b). We further analyzed the expression of several genes which exhibited hypomethyaltion in the gene body of several genes (*Cd47*, *Disc1*, *Dnm3*, *Evl*, *Sn8a*, and *Homer2*) in both male and female pups from HMFA in comparison with LMFA (Figure [2](#F2){ref-type="fig"}c, d). The result of gene expression in male pups revealed significant downregulation in the expression of *Evl* and *Homer2* whereas no such significant differences in expression of *Cd47*, *Disc1*, *Dnm3*, and *Sn8a* were observed. In contrast, in female pups, the expression of *Sn8a* was downregulated and the expressions of *Cd47*, *Disc1*, and *Evl* were upregulated whereas the expression of *Dnm3* did not exhibit any change in expression.

![**Distribution of differentially methylated sites in non CpG (CHG/CHH) sites. (a)** Male low maternal folic acid (LMFA) versus high maternal folic acid (HMFA). **(b)** Female LMFA versus HMFA.](1756-8935-7-3-3){#F3}

Maternal folic acid modulates sex-specific alterations in global DNA methylation in the offspring's cerebral hemispheres
------------------------------------------------------------------------------------------------------------------------

We further investigated the impact of maternal FA during gestation on epigenetic alterations throughout the genome in a sex-specific manner. Comparison between male and female pups' cerebral hemispheres from mothers fed an LMFA or HMFA revealed significant sexual dimorphism for global DNA methylation. Approximately 21% of the CpG sites were differentially methylated between males and females from both LMFA (n = 55,640) and HMFA (n = 45,634). The distributions of CpG-island and non-CpG island associated methylations between male and female are shown in Additional file [12](#S12){ref-type="supplementary-material"}: Figure S15 and Additional file [13](#S13){ref-type="supplementary-material"}: Figure S16a,b. The majority of the DMRs in CpG or non-CpG island between males and females from LMFA and HMFA were in intergenic or in introns, whereas 9% to 20% in exons and 10% to 21% were in promoter regions. Further analysis of the data revealed striking sexual dimorphism in methylation patterns of numerous genes as a result of both LMFA and HMFA (Additional file [14](#S14){ref-type="supplementary-material"}: Table S7, Additional file [15](#S15){ref-type="supplementary-material"}: Table S8, Additional file [16](#S16){ref-type="supplementary-material"}: Table S9, and Additional file [17](#S17){ref-type="supplementary-material"}: Table S10). The correlation of the distribution of methylation ratios between male and female pups for the corresponding sites in LMFA and HMFA is shown in Additional file [18](#S18){ref-type="supplementary-material"}: Figure S17a,b,c and Additional file [19](#S19){ref-type="supplementary-material"}: Figure S18a,b,c, and the hexbin plot (Additional file [20](#S20){ref-type="supplementary-material"}: Figure S19a,b,c) shows the distribution of the overlapped sites between genders of LMFA and HMFA from total significant (*P* \<0.05) differential methylation sites. To evaluate whether the expressions of the tested genes in this study were biased by gender, we analyzed the expression of several genes between male and female pups from LMFA and HMFA, which exhibited changes in methylation profile. First we compared the expression of genes *Trap1*, *Runx1*, *Scn8a*, and *Cd47* (hypermethylated) and *Auts2* and *Rnf111* (hypomethylated) in female pups from LMFA in comparison with LMFA from male pups (Additional file [21](#S21){ref-type="supplementary-material"}: Figure S20a). The results show that the expressions of *Trap1* and *Cd47* were significantly downregulated and the expression of *Runx1* was upregulated, whereas the expressions of *Scn8a*, *Auts2*, and *Rnf111* remained unchanged. Similarly, we compared the expression of genes *Dio3*, *Trim7*, *Shank3*, *Slc25a13*, *Auts2*, *Disc1*, and *Dnm3* (hypermethylated) and *Bag5*, *Ghr*, *Ror2*, and *Runx1* (hypomethylated) in female pups from HMFA in comparison with HMFA from male pups (Additional file [21](#S21){ref-type="supplementary-material"}: Figure S20b). The results show that the expressions of *Dio3*, *Trim7*, *Shank3*, *Slc25a13*, *Auts2*, *Disc1*, *Ror2*, and *Runx1* were upregulated, whereas the expressions of *Bag5* and *Ghr* were downregulated and the expression of *Dnm3* remained unchanged. These results show that expressions of several genes are biased between male and female pups both in the basal level (LMFA) and as a result of HMFA.

Moreover, to control and maintain the sexual-dimorphism hypothesis, we further analyzed the expression of several tested genes, which exhibited sexual dimorphism in methylation profile. For example, genes which exhibited changes in methylation level in male pups as a results of HMFA are tested in female pups (no changes in methylation profile); similarly, genes which exhibited changes in methylation level in female pups as a result of HMFA are tested in male pups (no change in methylation profile). The expression analysis of genes *Dio3*, *Polg2*, *Rnf111*, *Ube2s*, *Thsz3*, *Trim7*, *Gab1*, *Lats2*, and *Slc25a13* (hypermethylated, in female pups) and *Mrps12*, *Mtap4*, and *Ceacam2* (hypomethylated in female pups) were tested in male pups from HMFA in comparison with male pups from LMFA (Additional file [22](#S22){ref-type="supplementary-material"}: Figure S21a). The expression of *Rnf111* was upregulated and the expression of *Mrps12* (Figure [2](#F2){ref-type="fig"}c) was downregulated, whereas other tested genes did not exhibit any significant changes in male pups. It is interesting to note that the expressions of *Dio3* and *Slc25a13* were significantly downregulated and the expressions of *Thsz3* and *Mtap4* were significantly upregulated in female pups from HMFA in comparison with LMFA (Figure [2](#F2){ref-type="fig"}b, d). Similarly, we tested the expression of several genes in female pups from HMFA which exhibited no changes in methylation compared with female pups from LMFA. For example, the expressions of genes *Ada*, *Bag5*, *Trap1*, *Ghr*, *4732418C07Rik*, *Mthfd1l*, *Nfix*, *Otoa*, and *Slc22a3* (hypermethylated in male pups) and *Pcnxl3*, *Hmgb2l1*, and *Ror2* (hypomethyalted, in male pups) were tested. The results showed (Additional file [22](#S22){ref-type="supplementary-material"}: Figure S21b) that the expression of *Ada*, *Bag5*, and *Slc22a3* were unchanged in female pups from HMFA in comparison with LMFA. In contrast, the expressions of *Ghr* and *Nfix* were upregulated in female pups from HMFA. It is interesting to note that the expression of *Otoa* is downregulated whereas the expressions of *Trap1*, *4732418C07Rik*, *Mthfd1l, Pcnxl3*, *Hmgb2l1*, and *Ror2* remained unchanged in both male and female pups as results of HMFA. These results show that the expressions of several tested genes are sexually biased as a result of HMFA. Additionally, we have evaluated that the methylation patterns were affected in cis-alteration in CpG and CHG contexts in both males and females (Additional file [23](#S23){ref-type="supplementary-material"}: Table S11).

Discussion
==========

In a fertilized egg, global DNA demethylation followed by remethylation occurs to reprogram the maternal and paternal genomes for efficient regulation of gene expression. Certain genes are turned on and off at particular time intervals, and any disruption of such highly orchestrated methylation regulation may impact gene expression. The fetal epigenome is most vulnerable during this period of development to epigenetic modifiers in the maternal microenvironment. Because lifestyle and the level of nutrition available during gestation play an important role in the offsprings' gene regulation, maternal FA consumed could dictate the establishment of epigenetic patterns of the offspring. In this study, we found that HMFA during gestation resulted in substantial changes in the methylation profile of the offspring's cerebral hemispheres. Over the years, numerous studies have implicated several candidate autism susceptibility genes with a logical focus on the affected child. However, a consistent picture of specific susceptibility loci has thus far met with limited success \[[@B16]-[@B18]\]. In humans, FA during gestation has been shown to prevent autism or NTDs \[[@B19]-[@B21]\]. Intriguingly, our results showed hypermethylation but no hypomethylation in the promoter region of candidate autistic and imprinted genes in the offspring from the HMFA group. In this study, we found that HMFA resulted in hypermethylation (*P* \<0.01) at the CpG sites of the promoter region of *Ada* in male offspring. It is noteworthy that previous evidence had suggested decreased *Ada* activity in autistic subjects \[[@B22]-[@B24]\] and in a severe combined immune deficiency syndrome \[[@B25],[@B26]\]. Thus, such changes in methylation patterns in promoter CpG sites due to HMFA may have long-term influences on neuronal organization and behavioral phenotypes. In addition, epigenetic modifications of the imprinted genes such as *Dio3* can result in clinically significant phenotypes. It will be of interest to examine the impact of the dose and duration of maternal FA and the consequences of these epigenetic effects. Similar to hypermethylation, we observe hypomethylation in promoter regions of CpG sites in both male and female pups from HMFA in comparison with LMFA. The expression of *Ror2* (hypomethylated in male pups) which plays a role during neurogenesis of the developing neocortex \[[@B27]\] was significantly downregulated in male pups, but no such changes were observed in female pups. Moreover, the expression of *Mtap4* (hypomethylated in female pups) that has been shown to play a role in the central nervous system and regulation of the microtubule-dependent transport \[[@B28]\] was upregulated significantly in female pups from HMFA in comparison with LMFA, but the expression in male pups did not exhibit such significant changes. Intriguingly, the expression of *Mrsps12* that exhibited hypomethylation in female pups from HMFA remained unchanged in comparison with LMFA. In contrast, the expression of *Mrps12* in male pups was significantly downregulated in HMFA in comparison with LMFA, although no such changes in methylation pattern were observed. Of note, *Mrps12* is a major component of the ribosomal accuracy center and has been shown to play a role in sensorineural deafness \[[@B29]\].

Recently, the methylation of non-CpG regions and its role in transcriptional repression have received greater attention \[[@B30],[@B31]\], and single-base resolution maps of the human genome have revealed a substantial presence of methylated cytosine residues in non-CpG contexts \[[@B32]\]. In this study, we found substantial differential methylation in non-CpG regions in gene promoters from newborns of HMFA and confirmed the variations in the expression of several genes. Notably, studies using the brain tissue from an Alzheimer disease model \[[@B33]\], fetal brain \[[@B34],[@B35]\], adult tissues \[[@B36],[@B37]\], and early embryo \[[@B38]\] have shown that methylation in both CpG islands and non-CpG regions correlates with the expression of several genes. Thus, variation of methylation in the non-CpG regions as a result of HMFA may modulate epigenetic-mediated transcriptional repression, although a direct causal connection cannot be established with our data. Further analysis of the methylation profile has shown substantial differential methylation in the gene body of the offspring DNA. This finding builds on growing evidence that maternal adversity during gestation induces unbiased epigenetic changes in offspring genome. Although aberrant methylation in gene promoter regions is known to be linked with altered gene expression, the effect of hypermethylation in the gene body is unclear and inconclusive \[[@B39]\]. Significant evidence indicates that gene body methylation is a general feature of highly expressed genes in human cell lines \[[@B40]-[@B42]\]. In contrast, a recent study in a mouse model has revealed that differential gene body methylation generally resulted in downregulation of gene expression \[[@B43]\]. We found both up- and downregulation in the expression of transcripts that exhibited hypermethylation in the gene body of the offspring from HMFA. Our study suggests that the relationship between gene body methylation and transcriptional level may be more complicated than previously thought and, perhaps, underappreciated. Intriguingly the mRNA expression of *Shank3* was significantly downregulated in both male and female pups; in contrast, the expression of *Auts2* is downregulated in male pups but not in female pups. The genes *Auts2* and *Shank3* are associated with autism spectrum disorders and other neurological diseases \[[@B44],[@B45]\], and in this study both of the genes exhibited an alteration in methylation pattern in the gene body.

Our findings showed several distinct DMRs to be acting in a sexually dimorphic manner, similar to a recent study on imprinted genes in the placenta \[[@B46]\]. The relevance of epigenetic mechanisms in developing several complex diseases is sex-biased, and numerous studies have shown that during the developing windows of life the environmental factors, including nutrition during prenatal and postnatal life, influence epigenetic modulation in a sex-related manner \[[@B47]-[@B50]\]. Several studies in humans have further shown that various late-onset diseases are sex-biased and are highly related to maternal diet and body condition during pregnancy \[[@B51]-[@B53]\]. In this study, in the mouse model, we found that the expressions of several genes as a result of HMFA are highly biased in expression depending upon the gender. Furthermore, analysis of the methylation profile and gene expression between LMFA of male and female pups and between HMFA of male and female pups reveals striking sexual dimorphism. One possibility of such sexual dimorphism is the alterations in the uterine environment because of changes in FA level, and the methylation of imprinted genes may fine-tune selective events specific to one sex during developmental programming. Thus, the results of our study further highlight the relevance of studying both sexes in experimental models of maternal diet and may provide critical insight regarding the influence of FA in programming sex-biased methylation pattern.

It is paradoxical that the methylation profile of our findings shows a substantial hypomethylation to be present in the offspring DNA, even after supplementing HMFA. This finding indicates that the amount of gestational extracellular FA or cofactor required for the synthesis of S-adenosylmethionine probably can induce the site- and gene-specific nature of the methylation level in the offspring DNA, and probably the DNA methylation status is also dependent upon methylenetetrahydrofolate reductase (MTHFR) activity and not only on the folate status alone \[[@B54],[@B55]\]. Moreover, because DNA methylation is a distinguishing feature that varies between cell types, specifically various neuronal populations, the variation in methylation (hypo/hyper) profile of our sample may be due to the cellular heterogeneity of the cerebral hemisphere \[[@B56]-[@B58]\].

Methods
=======

Mice strain and feeding
-----------------------

Mice in this study were handled according to the protocol reviewed and approved by the Institute for Basic Research Institutional Animal Care and Use Committee. Adult, 8- to 10-week-old C57BL/6 J mice were used in all the experiments. Throughout the experimental procedure, controlled temperature and a fixed lighting schedule were maintained in the room. Given that most current commercial mice chow already contains quite high amounts of FA (2--3 mg/kg diet) and thus is unsuitable for the current studies, we developed a custom diet for this study. One week prior to mating, female mice were fed with a custom AIN-93G amino acid-based diet (Research Diet, Inc.), having FA at 0.4 mg/kg (n = 8--12), while the test group received FA at 4 mg/kg (n = 8--12). The diet was continued throughout the entire period of gestation.

Tissue collection and DNA extraction
------------------------------------

At postnatal day 1, six pups (n = 6, segregated by gender), all from different dams, in each diet group were sacrificed. Cerebral hemisphere tissues were pooled (n = 3/gender) for the 0.4 mg group: three male pups (each from an independent dam) and three female pups (each from an independent dam), for a total of six pups (n = 6). Tissues from six pups (n = 6, segregated by gender) from the 4 mg group were similarly processed. DNA was extracted from pooled cerebral hemispheres (n = 3/gender per group) with the Epicentre MasterPure DNA purification kit (Epicentre Biotechnologies, Madison, WI, USA) in accordance with the protocol of the manufacturer. After re-suspension in TE buffer, the DNA concentration was measured by using NanoDrop ND-1000 (Thermo Scientific, Wilmington, DE, USA).

Library construction
--------------------

To perform a genome-wide DNA methylation analysis, libraries were prepared from 200 to 500 ng of genomic DNA digested sequentially with 60 units of TaqI and 30 units of MspI (New England Biolabs, Ipswich, MA, USA). The resulting size-selected TaqI-MspI fragments (40--120 bp and 120--350 bp) were filled in, and 3′-terminal-A extended, extracted with DNA Clean & Concentrator™ kit (Zymo Research, Irvine, CA, USA). Ligation of selected fragments to pre-annealed adapters containing 5′-methyl-cytosine instead of cytosine was performed by using the Illumina DNA preparation kit in accordance with the protocol of the manufacturer (Illumina Inc., San Diego, CA, USA). Purified, adaptor-ligated fragments were then bisulphite-treated by using the EZ DNA Methylation-Direct™ Kit (Zymo Research). Preparative-scale PCR was performed with the resulting fragments followed by purification of PCR products with DNA Clean & Concentrator™ (Zymo Research). Final size selection of the purified PCR products was performed by using 4% NuSieve 3:1 agarose gel. SYBR-green-stained gel slices of adapter-ligated fragments (130--210 bp or 210--460 bp in size) were excised, and library material was recovered by using the Zymoclean™ Gel DNA Recovery Kit (Zymo Research). Sequencing was performed on an Illumina HiSeq genome analyzer.

Sequence alignments and data analysis
-------------------------------------

Using standard base-calling software, sequence reads from bisulfite-treated EpiQuest libraries were identified. Further analysis was performed by using a Zymo Research proprietary analysis pipeline. First, residual cytosines (Cs) in each read were converted to thymines (Ts), with each conversion noted for subsequent analysis. From the 50-bp ends of each computationally predicted MspI-TaqI fragment (40- to 350-bp size range), a reference sequence database was constructed. All Cs in each fragment end were then converted to Ts; only the C-poor strands are sequenced in the RRBS (reduced representation bisulfite sequencing) process. Then, using Bowtie software (<http://bowtie-bio.sourceforge.net/index.shtml>), the converted reads were aligned to the converted reference. The number of mismatches in the induced alignment was then counted between the unconverted read and reference, ignoring cases in which a T in the unconverted read was matched to a C in the unconverted reference. For a given read, the best alignment was kept if the second-best alignment had two more mismatches; otherwise, the read was discarded as non-unique. The methylation level of each sampled C was estimated as the number of reads reporting a C, divided by the total number of reads reporting a C or T. For each CpG site, Fisher's exact test or *t* test was performed, which covered at least five reads. Also, promoter, gene body, and CpG island annotations were added for each CpG. The software pipeline is implemented in Python. All the procedures above were carried out in the Zymo Epigentic Core Services (Zymo Research).

RNA preparation and quantitative real time reverse transcription-polymerase chain reaction analysis
---------------------------------------------------------------------------------------------------

At postnatal day 1, six pups (n = 6, segregated by gender) from different dams in each diet group were sacrificed. Cerebral hemisphere tissues were pooled (n = 3/gender) for the 0.4 mg group: three male pups (each from an independent dam) and three female pups (each from an independent dam), for a total of six pups (n = 6). Tissues from six pups (n = 6) from the 4 mg group were similarly processed. Considering the degree of inter-variability, RNA extractions were repeated from a different batch (pooled samples, n = 3 for each group/gender, with each mouse from a different dam). Total RNA was extracted by lysing the cells with Trizol reagent (Invitrogen Life Technologies, Inc., Carlsbad, CA, USA). Further purification of RNA was carried out using RNeasy kit (Qiagen, Valencia, CA, USA) in accordance with the instructions of the manufacturer. On-column DNase digestion for each sample was performed to remove any DNA contamination. The quality of RNA was assessed by measuring the absorbance ratio at 260/280 nm by using NanoDrop ND-1000 (Thermo Scientific). The integrity of RNA was further assessed by formaldehyde-gel electrophoresis. Quantitative real time reverse transcription-polymerase chain reaction amplifications were performed with either One-Step iScript kit (Bio-Rad, Hercules, CA, USA) or Two-step kit in which the first-strand cDNA from each sample was synthesized from 1 μg total RNA by using the First-Strand cDNA Synthesis kit (Affymetrix, Santa Clara, CA, USA) in accordance with the protocol of the manufacturer. qRT-PCR was performed by using the Mastercycler ep Realplex system (Eppendorf AG, Hamburg, Germany) in combination with the RT^2^ SYBRGreen PCR Master Mix (Qiagen). Each reaction was run in duplicate and repeated at least two times each from different batches of RNA (pooled n = 3 per batch/gender). *Hprt1* was used as endogenous control for amplification. Relative gene expression was calculated by using the Pfaffl method \[[@B59]\]. Primers used for qRT-PCR are listed in Additional file [24](#S24){ref-type="supplementary-material"}: Table S12. Statistical analysis was done by using Prism Software (GraphPad, San Diego, CA, USA). Values are presented as means ± standard deviation, and numerical results are presented considering *P* \<0.05 as significant.

Conclusions
===========

In summary, we have identified substantial DMRs in the cerebral hemispheres of the offspring, revealing that the HMFA diet causes epigenetic modifications. A key finding of this study is the presence of DMRs in non-CpG regions, along with CpG sites at single-base resolution, as a result of HMFA. Because numerous studies have shown that abnormalities in the frontal lobes impact brain development and autism \[[@B60],[@B61]\], our study's findings could provide a completely novel insight into the etiology of complex developmental disorders and foster the development of corrective strategies. However, we do not rule out the limitation of our study that the methylation and gene expression do not necessarily indicate change in function, and thus further studies are required in a larger number of samples to verify the functional outcome and phenotypes.
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Descriptive statistics of the mapping of methylation profile of the cerebral hemispheres of offspring from low maternal folic acid (LMFA) and high maternal folic acid (HMFA) diets.
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###### Additional file 2: Table S2

Genes in male offspring from high maternal folic acid (HMFA) diet, which were enriched with methylation in the gene body and other chromosomal regions in CpG/CHG/CHH contexts.
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###### Additional file 3: Table S3

Genes in female offspring from high maternal folic acid (HMFA), which were enriched with methylation in the gene body and other chromosomal region in CpG/CHG/CHH contexts.
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###### Additional file 4: Table S5

Genes that were hypomethylated in the CpG/CHG/CHH contexts of the male offspring from high maternal folic acid (HMFA) diet.
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###### Additional file 5: Table S6

Genes that were hypomethylated in the CpG/CHG/CHH region of the female offspring from high maternal folic acid (HMFA) diet.
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###### Additional file 6: Figures S1-S6

Scatter plot representing the distribution of the methylation ratio for corresponding sites of low maternal folic acid (LMFA) versus high maternal folic acid (HMFA). Pearson's correlation coefficient is denoted in the center of each scatter plot.
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###### Additional file 7: Figures S7-S9

Hexbin plot representing the overlapped sites in CpG (n = 4,378), CHG (n = 71), and CHH (n = 149) regions between male and female pups from high maternal folic acid (HMFA) in comparison with low maternal folic acid (LMFA) from total significant (*P* \<0.05) differential methylation sites. Each dot in hexbin plot is one of the overlapped sites. The colors blue, green, yellow and red represent the dot density from lower to higher order in accordance with the prevalence of the overlapping sites.
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###### Additional file 8: Figures S10, S11

Box plot illustrating the methylation levels across non-CpG islands of the cerebral hemispheres from male pups (S10) having low maternal folic acid (LMFA) (n = 36,319 and median = 0.65) and high maternal folic acid (HMFA) (n = 36,319 and median = 0.73) and from female pups (S11) having LMFA (n = 48,438 and median = 0.66) and HMFA (n = 48,438 and median = 0.69) as assessed by reduced representation bisulfite sequencing (RRBS). Boxes are 25th and 75th quartiles; horizontal yellow bar in the middle represents the median DNA methylation value. Whisker indicates the 5th and 95th percentiles.
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###### Additional file 9: Table S4

Genes in male and female offspring from high maternal folic acid (HMFA), which were enriched with methylation in the gene promoters in CHG/CHH.
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###### Additional file 10: Figure S12

A representative figure of the data uploaded in the University of California at Santa Cruz (UCSC) Genome Browser. Comparison of DNA methylation patterns in the offspring's cerebral hemisphere from low maternal folic acid (LMFA) and high maternal folic acid (HMFA). Example of the *Slc5a1* gene in chromosome 5 that was differentially methylated in the CHG contexts of promoter region of male offspring. Yellow color bars indicate gain of methylation.
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###### Additional file 11: Figures S13, S14

Box plot illustrating the methylation levels across exons of the cerebral hemispheres from male pups (S13) having low maternal folic acid (LMFA) (n = 8,136 and median = 0.42) and high maternal folic acid (HMFA) (n = 8,136 and median = 0.5) and from female pups (S14) having LMFA (n = 10,335 and median = 0.44) and HMFA (n = 10,335 and median = 0.5) as assessed by reduced representation bisulfite sequencing (RRBS). Boxes are 25th and 75th quartiles; horizontal yellow bar in the middle represents the median DNA methylation value. Whisker indicates the 5th and 95th percentiles.
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###### Additional file 12: Figure S15

Distribution of differentially methylated sites in CpG island sequences between males and females from (a) low maternal folic acid (LMFA) and (b) high maternal folic acid (HMFA).
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###### Additional file 13: Figure S16

Distribution of differentially methylated sites in non CpG island sequences between males and females from (a) low maternal folic acid (LMFA) and (b) high maternal folic acid (HMFA).
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###### Additional file 14: Table S7

Genes in female offspring from low maternal folic acid (LMFA) diet, which were enriched with methylation, compared with male offspring in the CpG/ CHG/CHH contexts.
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###### Additional file 15: Table S8

Genes in female offspring from low maternal folic acid (LMFA) diet, which were hypomethylated, compared with male offspring in the CpG/CHG/CHH contexts.
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###### Additional file 16: Table S9

Genes in female offspring from high maternal folic acid (HMFA) diet, which were enriched with methylation, compared with male offspring in the CpG/CHG/CHH contexts.
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###### Additional file 17: Table S10

Genes in female offspring from high maternal folic acid (HMFA) diet, which were hypomethylated, compared with male offspring in the promoter region in CpG/CHG/CHH contexts.
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###### Additional file 18: Figures S17 (a, b, c)

Scatter plot representing the distribution of the methylation ratio for corresponding sites of low maternal folic acid (LMFA) male versus LMFA female in CpG/CHG/CHH regions. Pearson's correlation coefficient is denoted in the center of each scatter plot.
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###### Additional file 19: Figures S18 (a, b, c)

Scatter plot representing the distribution of the methylation ratio for corresponding sites of high maternal folic acid (HMFA) male versus HMFA female in CpG/CHG/CHH regions. Pearson's correlation coefficient is denoted in the center of each scatter plot.
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###### Additional file 20: Figures S19 (a, b, c)

Hexbin plot representing the overlapped sites in CpG (n = 6,085), CHG (n = 96), and CHH (n = 154) regions between male and female pups from LMFA compared with high maternal folic acid (HMFA) pups from total significant (*P* \<0.05) differential methylation sites. Each dot in hexbin plot is one of the overlapped sites. The colors blue, green, yellow, and red represent the dot density from lower to higher order in accordance to the prevalence of the overlapping sites.
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###### Additional file 21: Figure S20a

Quantitative real time reverse transcription-polymerase chain reaction (qRT-PCR ) showing relative expression of the transcripts of genes in female pups that exhibited hypermethylation or hypomethyaltion in the cerebral hemispheres in comparison with male pups from low maternal folic acid (LMFA). The results were normalized to *Hprt* transcript expression and were expressed as relative values in comparison with corresponding transcripts from male LMFA. Results represent mean ± standard deviation (SD); asterisks denote statistically significant change (*\*P \<0.05,* \*\**P \<0.01, \*\*\*P \<0.001*). **Figure S20b.** qRT-PCR showing relative expression of the transcripts of genes in female pups that exhibited hypermethylation or hypomethyaltion in the cerebral hemispheres in comparison with male pups from high maternal folic acid (HMFA). The results were normalized to *Hprt* transcript expression and were expressed as relative values in comparison with corresponding transcripts from male HMFA. Results represent mean ± SD; asterisks denote statistically significant change (*\*P \<0.05,* \*\**P \<0.01, \*\*\*P \<0.001*).
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###### Additional file 22: Figure S21a

Quantitative real time reverse transcription-polymerase chain reaction (qRT-PCR) showing relative expression of the transcripts of genes in male pups from high maternal folic acid (HMFA) that exhibited no alterations in the methylation profile in promoter and gene body in the cerebral hemispheres compared with low maternal folic acid (LMFA). The results were normalized to *Hprt* transcript expression and were expressed as relative values in comparison with corresponding transcripts from LMFA. Results represent mean ± standard deviation (SD); asterisks denote statistically significant change (*\*P \<0.05,* \*\**P \<0.01, \*\*\*P \<0.001*). **Figure S21b.** qRT-PCR showing relative expression of the transcripts of genes in female pups from HMFA that exhibited no alterations in the methylation profile in promoter and gene body in the cerebral hemispheres compared with LMFA. The results were normalized to *Hprt* transcript expression and were expressed as relative values in comparison with corresponding transcripts from LMFA. Results represent mean ± SD; asterisks denote statistically significant change (*\*P \<0.05,* \*\**P \<0.01, \*\*\*P \<0.001*).
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###### Additional file 23: Table S11

List of top 100 sites, sorted by *P* value, which exhibited cis-alterations in male and female offspring in the CpG/CHG contexts.
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###### Additional file 24: Table S12

List of primers used for quantitative real time reverse transcription-polymerase chain reaction (qRT-PCR) in this study.
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